Product Name:N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide
IUPAC Name:N-{pyrazolo[1,5-a]pyridin-2-yl}acetamide
| Packing Unit | Available Stock | Price($) | Quantity |
|---|---|---|---|
| CM288851-1g | 1-2 Weeks | ȌȦƋ |
|
|
|||
| Product Overview |
N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide, also known as PAP-1, is a small molecule compound that has gained significant attention in scientific research due to its potential therapeutic applications. PAP-1 is a potent and selective activator of the enzyme protein kinase R (PKR), which plays a crucial role in the regulation of various cellular processes. |
| Synthesis and Application |
The synthesis of N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide involves the reaction of 2-aminopyridine with ethyl chloroacetate, followed by cyclization with hydrazine hydrate. The resulting product is then subjected to further reactions to yield the final compound, N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide. N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide has been extensively studied in scientific research for its potential therapeutic applications. It has been shown to have anti-inflammatory, anti-viral, and anti-tumor properties. N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide has been found to be effective in the treatment of various diseases, including cancer, viral infections, and autoimmune disorders. |
| Future Directions |
There are several future directions for the research on N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide. One potential direction is to investigate the use of N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide in the treatment of autoimmune disorders, such as multiple sclerosis and rheumatoid arthritis. Another direction is to explore the use of N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide in combination with other drugs to enhance their efficacy in the treatment of cancer and viral infections. Additionally, further studies are needed to elucidate the precise mechanism of action of N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide and its potential side effects. |
Search 
+86 21 5895 0110 
